SCHEMBL6964977

SCHEMBL6964977

N#Cc1ccccc1C1CCC(N2CC(N)C2)CC1

nearest known ligand 0.43

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ADRA1A P35348 2/20 0.43
CCRL2 O00421 1/20 0.40
CCR2 P41597 1/20 0.40
KCNH2 Q12809 1/20 0.40
TRPC6 Q9Y210 3/20 0.39
TRPC3 Q13507 1/20 0.39
MGLL Q99685 1/20 0.38
PROKR1 Q8TCW9 1/20 0.38
DRD4 P21917 1/20 0.37
AR P10275 1/20 0.35
KDM1A O60341 1/20 0.35
MAOA P21397 1/20 0.35
MAOB P27338 1/20 0.35
PDCD1 Q15116 1/20 0.35
CD274 Q9NZQ7 1/20 0.35
HCRTR2 O43614 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6961572 0.90 KDM1A (0.43) ADRA1ACCRL2CCR2KCNH2TRPC6
Hydrochloric Acid SCHEMBL7955138 0.90 KDM1A (0.43) ADRA1ACCRL2CCR2KCNH2TRPC6
SCHEMBL6964976 0.85 KDM4E (0.44) ADRA1ACCRL2CCR2KCNH2MGLL
SCHEMBL7707804 0.85 CCRL2 (0.41) ADRA1ACCRL2CCR2KCNH2MGLL
SCHEMBL7707353 0.85 CCRL2 (0.41) ADRA1ACCRL2CCR2KCNH2MGLL
Hydrochloric Acid SCHEMBL6956254 0.83 KDM4E (0.43) ADRA1ACCRL2CCR2KCNH2MGLL
Hydrochloric Acid SCHEMBL6956256 0.83 CCRL2 (0.40) ADRA1ACCRL2CCR2KCNH2MGLL
SCHEMBL29580963 0.80 ADRA1A (0.49) ADRA1APROKR1DRD4HCRTR2
SCHEMBL3167985 0.80 ADRA1A (0.49) ADRA1APROKR1DRD4HCRTR2
SCHEMBL7968202 0.77 ADRA1A (0.36) ADRA1ACCRL2CCR2KCNH2MGLL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0998285-A4 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS MERCK & CO INC (US) 2003-01-08 EP disclosed
US-6255315-B1 BENIGN PROSTATIC HYPERPLASIA MERCK & CO., INC. 2001-07-03 US disclosed
EP-0998285-A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS Merck & Co., Inc. (US) 2000-05-10 EP disclosed
US-6037354-A ADMINISTERING PHENYL-SUBSTITUTED THIAZOLIDIN-4-ONE OR OXAZOLIDIN-2-ONE DERIVATIVE TO TREAT BENIGN PROSTATE HYPERPLASIA; SIDE EFFECT REDUCTION MERCK & CO., INC. (US) 2000-03-14 US disclosed
WO-1998057641-A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS MERCK & CO., INC. (US) 1998-12-23 WO disclosed